Tag Archives: Infectious Disease

Medical Bed Mattresses FDA Safety Communication

Posted on May 2, 2013 by Ws Revelations

Translation Medical Bed Mattresses: FDA Safety Communication – Damaged or Worn Covers Pose Risk of Contamination and Infection AUDIENCE: Biomedical Engineering, Infectious Disease, Nursing, Risk Managers ISSUE: From January 2011 to January 2013, the FDA received 458 reports associated with … Continue reading →

Posted in Biomedical Engineering, FDA 2013, FDA Label Change, FDA Safety Communication, Infectious Disease, Nursing, Risk Manager | Tagged Biomedical Engineering, Drug Safety Communication, FDA notice, FDA Safety Communication, Infectious Disease, Medical Bed Mattresses, Medical Bed Mattresses FDA Safety Communication, Nursing, Risk Manager, Risk Managers, Safety Communication | Comments Off

BIVIGAM Immune Globulin Intravenous Recall

Posted on April 15, 2013 by Ws Revelations

TranslationBIVIGAM Immune Globulin Intravenous (Human), 10 Percent Liquid, 100 mL Sterile Vial: Recall – Visible Particles Observed AUDIENCE: Risk Manager, Infectious Disease, Health Professional ISSUE: During a routine annual reserve inspection, visible particles were observed in lot number 120016 (Expiration … Continue reading →

Posted in FDA 2013, FDA Recall, Healthcare Professionals, Infectious Disease, Risk Manager | Tagged (Human), 10 Percent Liquid, 100 mL, BIVIGAM Immune Globulin Intravenous, BIVIGAM Immune Globulin Intravenous Recall, Dexilant, drug risks, FDA recall, Gastroenterology, Health Professional, Infectious Disease, Recall, Risk Manager, Sterile Vial | Comments Off

Sterrad Cyclesure 24 Biological Indicator Safety Communication

Posted on July 6, 2012 by Ws Revelations

Translation Advanced Sterilization Products (ASP) Sterrad Cyclesure 24 Biological Indicator: Safety Communication – Potential Risk of Infection AUDIENCE: Risk Manager, Surgery, Infectious Disease ISSUE: An FDA review of ASP data showed that the Sterrad Cyclesure 24 Biological Indicators cannot effectively … Continue reading →

Posted in FDA 2012, FDA Safety Communication | Tagged Infectious Disease, Risk Manager, Safety Communication, Sterrad Cyclesure 24 Biological Indicator, Sterrad Cyclesure 24 Biological Indicator Safety Communication, Surgery | Comments Off

Cefepime Label Change drug risks

Posted on June 27, 2012 by Ws Revelations

TranslationCefepime:Label Change- Risk of Seizure in Patients Not Receiving Dosage Adjustments for Kidney Impairment Audience: Health Professional,Infectious Disease, Nephrology Issue: There have been cases of a specific type of seizure called nonconvulsive status epilepticus associated with the use of … Continue reading →

Posted in FDA 2012, FDA Warning, Healthcare Professionals, Infectious Disease, Nephrology | Tagged Adverse Effects, Cefepime, Cefepime Label Change, drug effects, drug reactions, drug risks, FDA warning, Health Professional, Infectious Disease, Nephrology, Risk of Seizure, safety label changes | Comments Off

Victrelis drug label revised Drug Safety Communication

Posted on April 26, 2012 by Ws Revelations

TranslationVictrelis (boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs: Drug Safety Communication – Drug Interactions [UPDATED 04/26/2012] FDA notified healthcare professionals that the Victrelis drug label has been revised to state that co-administration of Victrelis (boceprevir), a hepatitis … Continue reading →

Posted in FDA 2012, FDA Label Change, FDA Safety Communication, Infectious Disease, Pharmacy | Tagged drug interactions, drug risks, Drug Safety Communication, FDA notice, FDA warning, Infectious Disease, Pharmacy, Ritonavir-Boosted Human Immunodeficiency Virus (HIV), safety label changes, Victrelis (boceprevir) | Comments Off

Generic Ultrasound Transmission Gel Safety Communication

Posted on April 19, 2012 by Ws Revelations

TranslationOther‐Sonic Generic Ultrasound Transmission Gel: Safety Communication – Risk of Bacterial Contamination AUDIENCE: Risk Manager, OB/GYN, Radiology, Infectious Disease ISSUE: FDA notified health care professionals and facilities to STOP using Other‐Sonic Generic Ultrasound Transmission Gel manufactured June though December 2011, … Continue reading →

Posted in FDA 2012, FDA Warning, Infectious Disease, OBGYN, Radiology, Risk Manager | Tagged drug risks, FDA notice, Generic Ultrasound Transmission Gel, Infectious Disease, OBGYN, Other‐Sonic, Radiology, Risk Manager, Safety Communication | Comments Off

Statins and HIV or Hepatitis C Drugs Drug Safety Communication

Posted on March 2, 2012 by Ws Revelations

TranslationStatins and HIV or Hepatitis C Drugs: Drug Safety Communication – Interaction Increases Risk of Muscle Injury AUDIENCE: Infectious Disease, Family Practice, Patients ISSUE: FDA notified healthcare professionals of updates to the prescribing information concerning interactions between protease inhibitors and certain statin drugs. … Continue reading →

Posted in Family Practice, FDA 2012, FDA Safety Communication, Infectious Disease, Patients | Tagged drug interactions, drug risks, Drug Safety Communication, Family Practice, FDA notice, hiv, HIV or Hepatitis C Drugs, Infectious Disease, myopathy, Patients, protease inhibitors, Statins, Statins and HIV or Hepatitis C Drugs Drug Safety Communication | Comments Off

Diflucan (fluconazole) Birth Defects

Posted on August 4, 2011 by Ws Revelations

TranslationDiflucan (fluconazole): Drug Safety Communication – Long-term, High-dose Use During Pregnancy May Be Associated With Birth Defects AUDIENCE: OBGYN, Pharmacy, Infectious Disease ISSUE: FDA is informing the public that treatment with chronic, high doses (400-800mg/day) of Diflucan (fluconazole) during the … Continue reading →

Posted in FDA 2011, FDA Notice, FDA Warning, OBGYN, Pharmacy | Tagged Birth Defects, Diflucan, FDA notice, FDA warning, Fluconazole, Infectious Disease, OBGYN, Pharmacy | Comments Off

Zyvox (linezolid) Drug Safety Communication

Posted on July 26, 2011 by Ws Revelations

TranslationZyvox (linezolid): Drug Safety Communication – Serious CNS Reactions Possible When Given to Patients Taking Certain Psychiatric Medications AUDIENCE: Infectious Disease, Psychiatry, Family Practice ISSUE: FDA has received reports of serious central nervous system (CNS) reactions when the antibacterial … Continue reading →

Posted in Family Practice, FDA 2011, FDA Notice, Infectious Disease, Psychiatry | Tagged Drug Safety Communication, Family Practice, Infectious Disease, linezolid, Psychiatry, Zyvox | Comments Off